查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1268567

玻尿酸的全球市場的預測(～2027年)

Hyaluronic acid market Forecast to 2027
出版日期: | 出版商: Market Research Future | 英文 161 Pages | 訂單完成後即時交付

價格

本報告提供全球玻尿酸市場相關調查分析，市場動態，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 調查手法

第4章 市場動態

  • 簡介
  • 促進因素
    • 化妝品、個人保健產品的玻尿酸的使用增加
    • 美容整形手術的數量增加
    • 骨關節炎和乾眼症治療中玻尿酸的廣泛使用
  • 阻礙因素
    • 替代品的可得性
  • 機會
    • 玻尿酸關聯的廣泛研究開發
  • 趨勢
    • 動物用補充品的玻尿酸的使用

第5章 市場要素的分析

  • 供應鏈分析
    • 原料的供應商
    • 玻尿酸生產者
    • 流通/銷售管道
    • 終端用戶
  • 波特的五力分析
  • COVID-19影響的分析
    • 對成長率的影響
    • 對主要企業的影響
    • 對客戶偏好的影響
    • 對美容產業的影響

第6章 全球玻尿酸市場:各等級

  • 概要
  • 化妝品等級
  • 醫藥品等級
  • 食品等級

第7章 全球玻尿酸市場:各用途

  • 概要
  • 美容
  • 骨關節炎
  • 醫藥品原料藥
  • 化妝品
  • 營養補充品
  • 眼科
  • 其他

第8章 全球玻尿酸市場:各終端用戶

  • 概要
  • 製藥產業
  • 皮膚科診所，美容外科中心
  • 食品產業
  • 個人保養品
  • 其他

第9章 全球玻尿酸市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 比利時
    • 波蘭
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 其他的亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 土耳其
    • 南非
    • 以色列
    • 中東、非洲

第10章 競爭情形

  • 概要
  • 競爭基準
  • 全球玻尿酸市場上主要成長策略
  • 開發數的主要企業
  • 主要的發展與成長策略
    • 合資企業與契約
    • 行銷策略
    • 合併和收購
  • 財務矩陣

第11章 企業簡介

  • ALLERGAN PLC
  • CONTIPRO AS.
  • SYMATESE
  • ZHONGLAN INDUSTRY CO., LTD.
  • ALTERGON ITALIA SRL
  • FIDIA FARMACEUTICI S.P.A.
  • BIOIBERICA SAU.
  • KEWPIE CORPORATION
  • SEIKAGAKU CORPORATION
  • ANIKA THERAPEUTICS

第12章 附錄

Product Code: MRFR/HC/5965-CR

Market Overview

Increasing use of hyaluronic acid in cosmetic and personal care products, as well as an increase in the number of cosmetic surgeries. Hyaluronic acid is well known for its skin benefits such as reducing the appearance of fine lines, wrinkles, redness, and dermatitis. Hyaluronic acid aids in the retention of over 1,000 times its weight in water within skin cells, making it an excellent moisturiser. It promotes skin hydration and collagen production, combats free radicals, and maintains skin elasticity. It also functions as a humectant, a hygroscopic skincare ingredient that draws moisture from its surroundings. With consumer demand for anti-aging and multifunctional personal care products increasing, personal care product manufacturers are incorporating multi-functional and multiple ingredients into their products.

Segment Overview

The hyaluronic acid market is segmented based on grades, applications, end-users, and regions. The cosmetic grade segment accounted for the majority of the market revenue in 2021, due to its high demand as a cosmetic ingredient in personal care products. On the other hand, the pharmaceutical grade segment is the fastest-growing due to its use in treating various diseases and as a biomaterial. In terms of applications, the aesthetics segment dominated the market in 2021 due to consumer demand for minimally invasive cosmetic procedures. In terms of end-users, dermatology clinics held the largest market share in 2021 due to the use of hyaluronic acid-based fillers in skin treatments. North America had the largest market share in 2021, due to the presence of a large aging population and the growing demand for minimally invasive cosmetic surgeries.

Regional Analysis

Europe has the second-largest market share for hyaluronic acid due to rising aesthetic consciousness, rapid technological advancements, and shorter procedure times, among other factors driving the market in Europe. Furthermore, the German hyaluronic acid market held the largest market share, while the UK hyaluronic acid market was the fastest growing in the European region.

In the coming years, it is expected that the market for hyaluronic acid in the Asia-Pacific region will grow rapidly due to several factors such as growing unmet medical needs in developing economies, heightened knowledge of non-invasive procedures, and rising disposable income. Among the countries in the region, the China hyaluronic acid market currently holds the largest share, while the India hyaluronic acid market is growing at a rapid pace.

Major Players

Hyaluronic acid market is mainly dominated by Genzyme Corporation (US), Zimmer Biomet (US), Seikagaku Corporation (Japan), Hoffmann-La Roche Ag (Switzerland), Allergan (Ireland), Anika Therapeutics, Salix Pharmaceuticals (US), Sanofi (France), Inc. (US),Galderma Laboratories L.P. (US), and Smith & Nephew Plc (UK).

COVID 19 Impacts

The Covid-19 pandemic has had a significant impact on the global Hyaluronic Acid market. The initial spread of the virus caused many countries to impose lockdowns and restrictions on non-essential procedures, resulting in a slowdown in the demand for Hyaluronic Acid. This was particularly true in the cosmetic and aesthetic industry, where the use of Hyaluronic Acid is common. The halt of routine medical procedures and decreased consumer spending also contributed to a decrease in demand for Hyaluronic Acid.

However, as the pandemic has continued, the market has seen a gradual recovery as countries have started to lift restrictions and return to normal operations. In addition, the increased awareness of personal health and hygiene, as well as the need for medical procedures to treat the long-term effects of the virus, has led to a resurgence in demand for Hyaluronic Acid.

TABLE OF CONTENTS

LIST OF CONTENTS

1 EXECUTIVE SUMMARY 16

2 MARKET INTRODUCTION 18

  • 2.1 SCOPE OF THE STUDY 18
  • 2.2 RESEARCH OBJECTIVE 18
  • 2.3 MARKET STRUCTURE 18
  • 2.4 ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 20

  • 3.1 DATA MINING 20
  • 3.2 SECONDARY RESEARCH 21
  • 3.3 PRIMARY RESEARCH 22
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 23
  • 3.5 FORECASTING TECHNIQUES 24
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
    • 3.6.1 BOTTOM-UP APPROACH 26
    • 3.6.2 TOP-DOWN APPROACH 26
  • 3.7 DATA TRIANGULATION 27
  • 3.8 VALIDATION 27

4 MARKET DYNAMICS 28

  • 4.1 INTRODUCTION 28
  • 4.2 DRIVERS 29
    • 4.2.1 INCREASING APPLICATION OF HYALURONIC ACID IN COSMETIC & PERSONAL CARE PRODUCTS 29
    • 4.2.2 INCREASING NUMBER OF COSMETIC SURGERIES 31
    • 4.2.3 EXTENSIVE USE OF HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS AND DRY EYE 32
  • 4.3 RESTRAINTS 33
    • 4.3.1 AVAILABILITY OF SUBSTITUTES 33
  • 4.4 OPPORTUNITY 34
    • 4.4.1 EXTENSIVE R&D ASSOCIATED WITH HYALURONIC ACID 34
  • 4.5 TREND 35
    • 4.5.1 USE OF HYALURONIC ACID AS AN ANIMAL SUPPLEMENT 35

5 MARKET FACTOR ANALYSIS 36

  • 5.1 SUPPLY CHAIN ANALYSIS 36
    • 5.1.1 RAW MATERIAL SUPPLIERS 37
    • 5.1.2 HYALURONIC ACID PRODUCERS 37
    • 5.1.3 DISTRIBUTION & SALES CHANNEL 37
    • 5.1.4 END USERS 38
  • 5.2 PORTER'S FIVE FORCES MODEL 38
    • 5.2.1 BARGAINING POWER OF SUPPLIERS 39
    • 5.2.2 BARGAINING POWER OF BUYERS 39
    • 5.2.3 THREAT OF NEW ENTRANTS 39
    • 5.2.4 THREAT OF SUBSTITUTES 39
    • 5.2.5 INTENSITY OF RIVALRY 39
  • 5.3 COVID-19 IMPACT ANALYSIS 40
    • 5.3.1 IMPACT ON GROWTH RATE 40
    • 5.3.2 IMPACT ON MAJOR PLAYERS 40
    • 5.3.3 IMPACT ON PREFERENCE OF CUSTOMERS 40
    • 5.3.4 IMPACT ON AESTHETIC INDUSTRY 42

6 GLOBAL HYALURONIC ACID MARKET, BY GRADE 43

  • 6.1 OVERVIEW 43
  • 6.2 COSMETIC GRADE 45
  • 6.3 PHARMACEUTICAL GRADE 46
  • 6.4 FOOD GRADE 47

7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION 48

  • 7.1 OVERVIEW 48
  • 7.2 AESTHETICS 49
  • 7.3 OSTEOARTHRITIS 50
  • 7.4 PHARMACEUTICAL API 51
  • 7.5 COSMETICS 52
  • 7.6 DIETARY SUPPLEMENTS 53
  • 7.7 OPHTHALMOLOGY 54
  • 7.8 OTHERS 54

8 GLOBAL HYALURONIC ACID MARKET, BY END USER 56

  • 8.1 OVERVIEW 56
  • 8.2 PHARMACEUTICAL INDUSTRY 58
  • 8.3 DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS 59
  • 8.4 FOOD INDUSTRY 60
  • 8.5 PERSONAL CARE 61
  • 8.6 OTHERS 61

9 GLOBAL HYALURONIC ACID MARKET, BY REGION 63

  • 9.1 OVERVIEW 63
  • 9.2 NORTH AMERICA 65
    • 9.2.1 US 67
    • 9.2.2 CANADA 69
  • 9.3 EUROPE 71
    • 9.3.1 FRANCE 74
    • 9.3.2 GERMANY 75
    • 9.3.3 UK 77
    • 9.3.4 SPAIN 78
    • 9.3.5 ITALY 80
    • 9.3.6 RUSSIA 81
    • 9.3.7 BELGIUM 83
    • 9.3.8 POLAND 84
    • 9.3.9 REST OF EUROPE 86
  • 9.4 ASIA-PACIFIC 88
    • 9.4.1 CHINA 91
    • 9.4.2 JAPAN 92
    • 9.4.3 INDIA 94
    • 9.4.4 SOUTH KOREA 95
    • 9.4.5 AUSTRALIA 97
    • 9.4.6 THAILAND 98
    • 9.4.7 INDONESIA 100
    • 9.4.8 REST OF ASIA-PACIFIC 101
  • 9.5 LATIN AMERICA 103
    • 9.5.1 BRAZIL 105
    • 9.5.2 MEXICO 107
    • 9.5.3 ARGENTINA 108
    • 9.5.4 REST OF LATIN AMERICA 110
  • 9.6 MIDDLE EAST & AFRICA 112
    • 9.6.1 SAUDI ARABIA 115
    • 9.6.2 UAE 116
    • 9.6.3 TURKEY 118
    • 9.6.4 SOUTH AFRICA 119
    • 9.6.5 ISRAEL 121
    • 9.6.6 REST OF THE MIDDLE EAST &AFRICA 122

10 COMPETITIVE LANDSCAPE 124

  • 10.1 OVERVIEW 124
  • 10.2 COMPETITIVE BENCHMARKING 125
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HYALURONIC ACID MARKET 127
  • 10.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 128
  • 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 129
    • 10.5.1 JOINT VENTURES & AGREEMENTS 130
    • 10.5.2 MARKETING STRATEGY 130
    • 10.5.3 MERGERS&ACQUISITIONS 130
  • 10.6 FINANCIAL MATRIX 131

11 COMPANY PROFILES 132

  • 11.1 ALLERGAN PLC 132
    • 11.1.1 COMPANY OVERVIEW 132
    • 11.1.2 FINANCIAL OVERVIEW 133
    • 11.1.3 PRODUCTS/SERVICES OFFERED 133
    • 11.1.4 KEY DEVELOPMENTS 134
    • 11.1.5 SWOT ANALYSIS 134
    • 11.1.6 KEY STRATEGIES 135
  • 11.2 CONTIPRO AS. 136
    • 11.2.1 COMPANY OVERVIEW 136
    • 11.2.2 FINANCIAL OVERVIEW 136
    • 11.2.3 PRODUCTS OFFERED 136
    • 11.2.4 KEY DEVELOPMENTS 137
    • 11.2.5 SWOT ANALYSIS 137
    • 11.2.6 KEY STRATEGIES 137
  • 11.3 SYMATESE 138
    • 11.3.1 COMPANY OVERVIEW 138
    • 11.3.2 FINANCIAL OVERVIEW 138
    • 11.3.3 PRODUCTS OFFERED 138
    • 11.3.4 KEY DEVELOPMENTS 138
    • 11.3.5 SWOT ANALYSIS 139
    • 11.3.6 KEY STRATEGIES 139
  • 11.4 ZHONGLAN INDUSTRY CO., LTD. 140
    • 11.4.1 COMPANY OVERVIEW 140
    • 11.4.2 FINANCIAL OVERVIEW 140
    • 11.4.3 PRODUCTS OFFERED 140
    • 11.4.4 KEY DEVELOPMENTS 140
    • 11.4.5 SWOT ANALYSIS 141
    • 11.4.6 KEY STRATEGIES 141
  • 11.5 ALTERGON ITALIA SRL 142
    • 11.5.1 COMPANY OVERVIEW 142
    • 11.5.2 FINANCIAL OVERVIEW 142
    • 11.5.3 PRODUCTS OFFERED 142
    • 11.5.4 KEY DEVELOPMENTS 142
    • 11.5.5 SWOT ANALYSIS 143
    • 11.5.6 KEY STRATEGIES 143
  • 11.6 FIDIA FARMACEUTICI S.P.A. 144
    • 11.6.1 COMPANY OVERVIEW 144
    • 11.6.2 FINANCIAL OVERVIEW 144
    • 11.6.3 PRODUCTS OFFERED 144
    • 11.6.4 KEY DEVELOPMENTS 144
    • 11.6.5 SWOT ANALYSIS 145
    • 11.6.6 KEY STRATEGIES 145
  • 11.7 BIOIBERICA SAU. 146
    • 11.7.1 COMPANY OVERVIEW 146
    • 11.7.2 FINANCIAL OVERVIEW 146
    • 11.7.3 PRODUCTS OFFERED 146
    • 11.7.4 KEY DEVELOPMENTS 146
    • 11.7.5 SWOT ANALYSIS 147
    • 11.7.6 KEY STRATEGIES 147
  • 11.8 KEWPIE CORPORATION 148
    • 11.8.1 COMPANY OVERVIEW 148
    • 11.8.2 FINANCIAL OVERVIEW 148
    • 11.8.3 PRODUCTS OFFERED 149
    • 11.8.4 KEY DEVELOPMENTS 149
    • 11.8.5 SWOT ANALYSIS 150
    • 11.8.6 KEY STRATEGIES 150
  • 11.9 SEIKAGAKU CORPORATION 151
    • 11.9.1 COMPANY OVERVIEW 151
    • 11.9.2 FINANCIAL OVERVIEW 152
    • 11.9.3 PRODUCTS OFFERED 153
    • 11.9.4 KEY DEVELOPMENTS 153
    • 11.9.5 SWOT ANALYSIS 154
    • 11.9.6 KEY STRATEGIES 154
  • 11.10 ANIKA THERAPEUTICS 155
    • 11.10.1 COMPANY OVERVIEW 155
    • 11.10.2 FINANCIAL OVERVIEW 156
    • 11.10.3 PRODUCTS/SERVICES OFFERED 157
    • 11.10.4 KEY DEVELOPMENTS 157
    • 11.10.5 SWOT ANALYSIS 158
    • 11.10.6 KEY STRATEGIES 158

12 APPENDIX 159

  • 12.1 REFERENCES 159
  • 12.2 RELATED REPORTS 160

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22
  • TABLE 3 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 44
  • TABLE 4 GLOBAL HYALURONIC ACID MARKET FOR COSMETIC GRADE, BY REGION, 2018-2027 (USD MILLION) 45
  • TABLE 5 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL GRADE, BY REGION, 2018-2027 (USD MILLION) 46
  • TABLE 6 GLOBAL HYALURONIC ACID MARKET FOR FOOD-GRADE, BY REGION, 2018-2027 (USD MILLION) 47
  • TABLE 7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 49
  • TABLE 8 GLOBAL HYALURONIC ACID MARKET FOR AESTHETICS, BY REGION, 2018-2027 (USD MILLION) 49
  • TABLE 9 GLOBAL HYALURONIC ACID MARKET FOR OSTEOARTHRITIS, BY REGION, 2018-2027 (USD MILLION) 50
  • TABLE 10 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL API, BY REGION, 2018-2027 (USD MILLION) 51
  • TABLE 11 GLOBAL HYALURONIC ACID MARKET FOR COSMETICS, BY REGION, 2018-2027 (USD MILLION) 52
  • TABLE 12 GLOBAL HYALURONIC ACID MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2018-2027 (USD MILLION) 53
  • TABLE 13 GLOBAL HYALURONIC ACID MARKET FOR OPHTHALMOLOGY, BY REGION, 2018-2027 (USD MILLION) 54
  • TABLE 14 GLOBAL HYALURONIC ACID MARKET, BY OPHTHALMOLOGY, FOR TYPE, 2018-2027 (USD MILLION) 54
  • TABLE 15 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION) 55
  • TABLE 16 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 57
  • TABLE 17 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2018-2027 (USD MILLION) 58
  • TABLE 18 GLOBAL HYALURONIC ACID MARKET FOR DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS, BY REGION, 2018-2027 (USD MILLION) 59
  • TABLE 19 GLOBAL HYALURONIC ACID MARKET FOR FOOD INDUSTRY, BY REGION, 2018-2027 (USD MILLION) 60
  • TABLE 20 GLOBAL HYALURONIC ACID MARKET FOR PERSONAL CARE, BY REGION, 2018-2027 (USD MILLION) 61
  • TABLE 21 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION) 61
  • TABLE 22 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2018-2027 (USD MILLION) 64
  • TABLE 23 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 65
  • TABLE 24 NORTH AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 66
  • TABLE 25 NORTH AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 66
  • TABLE 26 NORTH AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 67
  • TABLE 27 US: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 67
  • TABLE 28 US: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 68
  • TABLE 29 US: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 68
  • TABLE 30 CANADA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 69
  • TABLE 31 CANADA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 69
  • TABLE 32 CANADA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 70
  • TABLE 33 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 72
  • TABLE 34 EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 72
  • TABLE 35 EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 73
  • TABLE 36 EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 73
  • TABLE 37 FRANCE: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 74
  • TABLE 38 FRANCE: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 74
  • TABLE 39 FRANCE: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 75
  • TABLE 40 GERMANY: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 75
  • TABLE 41 GERMANY: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 76
  • TABLE 42 GERMANY: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 76
  • TABLE 43 UK: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 77
  • TABLE 44 UK: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 77
  • TABLE 45 UK: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 78
  • TABLE 46 SPAIN: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 78
  • TABLE 47 SPAIN: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 79
  • TABLE 48 SPAIN: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 79
  • TABLE 49 ITALY: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 80
  • TABLE 50 ITALY: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 80
  • TABLE 51 ITALY: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 81
  • TABLE 52 RUSSIA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 81
  • TABLE 53 RUSSIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 82
  • TABLE 54 RUSSIA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 82
  • TABLE 55 BELGIUM: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 83
  • TABLE 56 BELGIUM: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 83
  • TABLE 57 BELGIUM: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 84
  • TABLE 58 POLAND: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 84
  • TABLE 59 POLAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 85
  • TABLE 60 POLAND: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 85
  • TABLE 61 REST OF EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 86
  • TABLE 62 REST OF EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 86
  • TABLE 63 REST OF EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 87
  • TABLE 64 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 89
  • TABLE 65 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 89
  • TABLE 66 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 90
  • TABLE 67 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 90
  • TABLE 68 CHINA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 91
  • TABLE 69 CHINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 91
  • TABLE 70 CHINA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 92
  • TABLE 71 JAPAN: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 92
  • TABLE 72 JAPAN: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 93
  • TABLE 73 JAPAN: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 93
  • TABLE 74 INDIA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 94
  • TABLE 75 INDIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 94
  • TABLE 76 INDIA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 95
  • TABLE 77 SOUTH KOREA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 95
  • TABLE 78 SOUTH KOREA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 96
  • TABLE 79 SOUTH KOREA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 96
  • TABLE 80 AUSTRALIA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 97
  • TABLE 81 AUSTRALIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 97
  • TABLE 82 AUSTRALIA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 98
  • TABLE 83 THAILAND: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 98
  • TABLE 84 THAILAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 99
  • TABLE 85 THAILAND: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 99
  • TABLE 86 INDONESIA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 100
  • TABLE 87 INDONESIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 100
  • TABLE 88 INDONESIA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 101
  • TABLE 89 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 101
  • TABLE 90 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 102
  • TABLE 91 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 102
  • TABLE 92 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 104
  • TABLE 93 LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 104
  • TABLE 94 LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 104
  • TABLE 95 LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 105
  • TABLE 96 BRAZIL: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 105
  • TABLE 97 BRAZIL: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 106
  • TABLE 98 BRAZIL: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 106
  • TABLE 99 MEXICO: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 107
  • TABLE 100 MEXICO: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 107
  • TABLE 101 MEXICO: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 108
  • TABLE 102 ARGENTINA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 108
  • TABLE 103 ARGENTINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 109
  • TABLE 104 ARGENTINA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 109
  • TABLE 105 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 110
  • TABLE 106 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 110
  • TABLE 107 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 111
  • TABLE 108 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 113
  • TABLE 109 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 113
  • TABLE 110 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 114
  • TABLE 111 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 114
  • TABLE 112 SAUDI ARABIA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 115
  • TABLE 113 SAUDI ARABIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 115
  • TABLE 114 SAUDI ARABIA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 116
  • TABLE 115 UAE: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 116
  • TABLE 116 UAE: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 117
  • TABLE 117 UAE: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 117
  • TABLE 118 TURKEY: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 118
  • TABLE 119 TURKEY: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 118
  • TABLE 120 TURKEY: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 119
  • TABLE 121 SOUTH AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 119
  • TABLE 122 SOUTH AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 120
  • TABLE 123 SOUTH AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 120
  • TABLE 124 ISRAEL: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 121
  • TABLE 125 ISRAEL: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 121
  • TABLE 126 ISRAEL: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 122
  • TABLE 127 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018-2027 (USD MILLION) 122
  • TABLE 128 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 123
  • TABLE 129 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018-2027 (USD MILLION) 123
  • TABLE 130 GLOBAL HYALURONIC ACID MARKET: COMPANY RANKING 126
  • TABLE 131 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL HYALURONIC ACID MARKET 128
  • TABLE 132 PRODUCT APPROVALS & PRODUCT LAUNCHES 129
  • TABLE 133 JOINT VENTURES & AGREEMENTS 130
  • TABLE 134 MARKETING STRATEGY 130
  • TABLE 135 MERGER & ACQUISITION 130
  • TABLE 136 ALLERGAN PLC: PRODUCTS/SERVICES OFFERED 133
  • TABLE 137 ALLERGAN: KEY DEVELOPMENTS 134
  • TABLE 138 CONTIPRO AS: PRODUCTS OFFERED 136
  • TABLE 139 CONTIPRO AS: KEY DEVELOPMENTS 137
  • TABLE 140 SYMATESE: PRODUCTS OFFERED 138
  • TABLE 141 SYMATESE: KEY DEVELOPMENTS 138
  • TABLE 142 ZHONGLAN INDUSTRY CO., LTD: PRODUCTS OFFERED 140
  • TABLE 143 ALTERGON ITALIA SRL: PRODUCTS OFFERED 142
  • TABLE 144 FIDIA FARMACEUTICI SPA: PRODUCTS OFFERED 144
  • TABLE 145 FIDIA FARMACEUTICI SPA: KEY DEVELOPMENTS 144
  • TABLE 146 BIOIBERICA SAU: PRODUCTS OFFERED 146
  • TABLE 147 BIOIBERICA SAU: KEY DEVELOPMENTS 146
  • TABLE 148 KEWPIE CORPORATION: PRODUCTS OFFERED 149
  • TABLE 149 SEIKAGAKU CORPORATION: PRODUCTS OFFERED 153
  • TABLE 150 SEIKAGAKU CORPORATION: KEY DEVELOPMENTS 153
  • TABLE 151 ANIKA THERAPEUTICS: PRODUCTS/SERVICES OFFERED 157
  • TABLE 152 ANIKA THERAPEUTICS: KEY DEVELOPMENTS 157

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 17
  • FIGURE 2 HYALURONIC ACID MARKET STRUCTURE 18
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 25
  • FIGURE 4 MARKET DYNAMICS OVERVIEW 28
  • FIGURE 5 TRADE DATA FOR SKINCARE PRODUCTS (USD MILLION) 29
  • FIGURE 6 GROWTH OF THE GLOBAL COSMETICS MARKET (%) 30
  • FIGURE 7 TOP 5 COUNTRIES FOR COSMETIC PROCEDURES, 2019 31
  • FIGURE 8 DRIVERS IMPACT ANALYSIS 33
  • FIGURE 9 RESTRAINT IMPACT ANALYSIS 34
  • FIGURE 10 SUPPLY CHAIN: GLOBAL HYALURONIC ACID MARKET 36
  • FIGURE 11 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HYALURONIC ACID MARKET 38
  • FIGURE 12 GLOBAL HYALURONIC ACID MARKET SHARE, BY GRADE, 2020 (%) 43
  • FIGURE 13 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2020 & 2027 (USD MILLION) 44
  • FIGURE 14 GLOBAL HYALURONIC ACID MARKET SHARE, BY APPLICATION, 2020 (%) 48
  • FIGURE 15 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 48
  • FIGURE 16 GLOBAL HYALURONIC ACID MARKET SHARE, BY END USER, 2020 (%) 56
  • FIGURE 17 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2020 & 2027 (USD MILLION) 57
  • FIGURE 18 GLOBAL HYALURONIC ACID MARKET SHARE, BY REGION, 2020 (%) 63
  • FIGURE 19 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2020 & 2027 (USD MILLION) 64
  • FIGURE 20 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 65
  • FIGURE 21 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 71
  • FIGURE 22 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 88
  • FIGURE 23 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 103
  • FIGURE 24 MIDDLE EAST &AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 112
  • FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 125
  • FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL HYALURONIC ACID MARKET 127
  • FIGURE 27 GLOBAL HYALURONIC ACID MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 129
  • FIGURE 28 SALES, 2020 131
  • FIGURE 29 R&D EXPENDITURE, 2020 131
  • FIGURE 30 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT 133
  • FIGURE 31 ALLERGAN: SWOT ANALYSIS 134
  • FIGURE 32 CONTIPRO AS: SWOT ANALYSIS 137
  • FIGURE 33 SYMATESE: SWOT ANALYSIS 139
  • FIGURE 34 ZHONGLAN INDUSTRY CO., LTD: SWOT ANALYSIS 141
  • FIGURE 35 ALTERGON ITALIA SRL: SWOT ANALYSIS 143
  • FIGURE 36 FIDIA FARMACEUTICI SPA: SWOT ANALYSIS 145
  • FIGURE 37 BIOIBERICA SAU: SWOT ANALYSIS 147
  • FIGURE 38 KEWPIE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 148
  • FIGURE 39 KEWPIE CORPORATION: SWOT ANALYSIS 150
  • FIGURE 40 SEIKAGAKU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 152
  • FIGURE 41 SEIKAGAKU CORPORATION: SWOT ANALYSIS 154
  • FIGURE 42 ANIKA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT 156
  • FIGURE 43 ANIKA THERAPEUTICS INC.: SWOT ANALYSIS 158